US2010278943A1PendingUtilityA1

Anti viral composition

52
Assignee: SAMBANTHAMURTHI RAVIGADEVIPriority: Jul 23, 2007Filed: Jul 23, 2008Published: Nov 4, 2010
Est. expiryJul 23, 2027(~1 yrs left)· nominal 20-yr term from priority
Inventors:Ravigadevi SambanthamurthiKalyana SundramYew Ai Tan
A61P 31/18A61K 31/353A61K 31/047A61K 36/889A61P 31/12A61K 31/192
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a composition enriched in but not confined to phenolic antioxidants obtained from oil palm, and more particularly this invention relates to a composition for promoting immunity in general and most essentially against Human Immunodeficiency Virus (HIV) and HCV related infections. Accordingly, the composition having the said oil palm compounds can effectively inhibit various viruses, further supporting oil palm compounds as one of the broad spectrum antiviral drugs.

Claims

exact text as granted — not AI-modified
1 - 7 . (canceled) 
     
     
         8 . A composition comprising extracts from oil palm vegetation liquor for use in inhibiting the replication of human immunodeficiency virus (HIV) and thereby preventing HIV infections; characterized in that the composition provides inhibitory action against protease and reverse transcriptase activity. 
     
     
         9 . The composition as claimed in  claim 8  wherein the composition is for use in inhibiting replication of Hepatitis C virus (HCV) and thereby preventing HCV infections. 
     
     
         10 . The composition as claimed in  claim 8  wherein the extracts from oil palm vegetation liquor comprises phenolic compounds, fruit acids, fruit sugars and glycerol. 
     
     
         11 . The composition as claimed in  claim 8  wherein they may be provided as compounds with pharmaceutically acceptable carriers. 
     
     
         12 . A method of preventing HIV or HCV infections in a patient, said method comprising administering a therapeutically effective amount of a composition of  claim 8  to said patient. 
     
     
         13 . A method of preventing HCV infection in a patient, said method comprising administering a therapeutically effective amount of a composition of  claim 8  to said patient. 
     
     
         14 . The method of  claim 12 , wherein the composition is administered orally or as supplements. 
     
     
         15 . The method of  claim 13 , wherein the composition is administered orally or as supplements. 
     
     
         16 . The method of  claim 12 , wherein the composition is administered together with additives.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.